Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 13/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.47 |
| ▸ | TACR2 | P21452 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | DHODH | Q02127 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8617740 | 0.90 | TACR3 (0.51) | TACR3KDM4ETACR2DHODH | |
| SCHEMBL8616548 | 0.86 | TACR3 (0.52) | TACR3KDM4EALDH1A1LMNAGAA | |
| SCHEMBL8614161 | 0.85 | LMNA (0.61) | TACR3KDM4EALDH1A1LMNAGAA | |
| SCHEMBL8619733 | 0.83 | DHODH (0.58) | TACR3KDM4EALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL8615299 | 0.82 | TACR3 (0.49) | TACR3KDM4EALDH1A1LMNATACR2 | |
| SCHEMBL8619398 | 0.81 | TACR3 (0.59) | TACR3KDM4EALDH1A1PTGER4TACR2 | |
| SCHEMBL8617743 | 0.80 | CYP3A4 (0.65) | TACR3KDM4EALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL8618943 | 0.79 | MEN1 (0.65) | TACR3KDM4EALDH1A1LMNAGAA | |
| SCHEMBL8619034 | 0.79 | DHODH (0.57) | TACR3KDM4EALDH1A1TACR2DHODH | |
| SCHEMBL8614314 | 0.79 | KMT2A (0.65) | TACR3KDM4EALDH1A1LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0726254-B1 | Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds | MITSUI TOATSU CHEMICALS (JP) | 1998-05-06 | — | — | EP | disclosed |
| US-5627193-A | MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION | MITSUI TOATSU CHEMICALS, INC. (JP) | 1997-05-06 | — | — | US | disclosed |
| EP-0726254-A1 | Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1996-08-14 | — | — | EP | disclosed |